Access Construction Market Insight reports

Close button
...
APAC

Project controls for a biotechnology company’s portfolio of projects

Linesight was engaged by one of the leading biotechnology companies in the world to provide commercial and project controls services for their portfolio of projects in Singapore.

Key Contact

John Butler

John Butler

Managing Director – APAC and GCC

APAC

john.butler@linesight.com

+65 6801 4540

Contact Representative

Linesight was engaged by one of the leading biotechnology companies in the world to provide commercial and project controls services for their portfolio of projects in Singapore. The confidential client’s portfolio comprised a single product facility, a new manufacturing support building, approximately 4,000 sq.ft. biologics lab, a waste water treatment plant, and a training and biologics testing facility.  

Value Add

Linesight worked closely with the client to develop a detailed project plan and scope of work to ensure on time and within budget project delivery. The team developed a comprehensive cost estimate, taking into account all labour, materials, equipment, and other expenses associated with the project. 

Monitoring project progress and performance also involved tracking key performance indicators, such as schedule adherence, cash flow and cost position. We also set the scene for transparency by keeping the client informed of the project’s status through regular reports and update meetings.  

Linesight’s life sciences sectoral expertise, both locally and globally, was instrumental in helping the client manage their portfolio with confidence.

Data

4,000 sq.ft.

John Butler

John Butler

Managing Director – APAC and GCC

APAC

Latest Insights

3rd April 2024

Gul Dusi on navigating Life Sciences construction in California

It's hard to understate what a powerhouse California has become in the life sciences industry. The state is the largest employer of life sciences workers in the US and has added more jobs in the sector than any other state over the last decade.

Continue Reading